imagem top

2023

ANUÁRIO DO HOSPITAL
DONA ESTEFÂNIA

CHULC LOGOlogo HDElogo anuario

THE DANGERS OF UNDERVALUING DRUG ALLERGY HISTORY

Pedro Simão Coelho1, Gonçalo Martins dos Santos1, Mila Mikovic1, João Oliveira2, Sónia Rosa1, Paula Leiria Pinto1, Eduardo Silva2

1 - Serviço de Imunoalergologia, Centro Hospitalar Universitário de Lisboa Central
2 - Serviço de Medicina Interna 2.3, Centro Hospitalar Universitário de Lisboa Central

- EAACI Hybrid Congress 2022

BACKGROUND. Drug hypersensitivity reactions (DHR) are frequently self-reported by patients, but are usually mistaken for predictable adverse drug reactions, infectious manifestations, or other conditions. The majority are not confirmed after a careful evaluation; however, this is seldom done, leading to both overdiagnosis of drug allergy and undervaluation due to lack of confirmation. This study intends to evaluate the consequences of devaluing a self-reported diagnosis of drug allergy.
METHODS. Retrospective study conducted in an Internal Medicine ward from a tertiary hospital in Lisbon, Portugal. All patients admitted between January 2018 and December 2020 with a drug allergy report on their electronic medical records were included. Data was collected from electronic medical records.
RESULTS. Of a total of 3046 patients, 470 (15%) were selected due to their reported allergy history. The suspected drug was administered on 15% (n=69) of patients: 54 (78%) antibiotics, 7 (10%) non-steroid anti-inflammatory drugs, 2 (3%) radiocontrast media (RCM), 2 (3%) bronchodilators, and 4 (6%) other drugs. A clear medical history of past events was present in 49% (n=34) of these patients, with 29 reporting immediate symptoms (minutes to hours) and 5 describing late reactions (days). A total of 12 (17%) patients had previously received the suspected drug in the hospital setting, 11 (92%) tolerated the drug and 1 (8%) had a mucocutaneous reaction description, all of which were reproducible. After administration of the suspected drug, 87% (n=60) of the patients presented no reaction and 13% (n=9) developed a reaction assumed by the attending physician as an allergic reaction, one of which an anaphylaxis. Six (67%) patients presented similar reactions as previously described. The other 3 (33%) patients, either had a different timing reaction or no previous report to compare with. None was referred to our Allergy and Clinical Immunology Department.
CONCLUSION. A self-report of a drug allergy may be real and devaluing such history can be associated with avoidable life-threating reactions. Past medical records are fundamental to help distinguish between a possible and a less probable allergy. An evaluation by an immunoallergy specialist should always be performed to confirm or exclude the diagnosis.

Palavras Chave: fármacos, hipersensibilidade